Biolojic Design Appoints Roger Waltzman as Chief Medical Officer | Biolojic Design

Categories: News | Published On: January 11, 2026 | Written by webadmin@biolojic.com |

Biolojic Design Appoints Roger Waltzman as Chief Medical Officer

More News

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
Read More
Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024
Read More

BUSINESS AND MEDIA INQUIRIES

Micah Pearlman
micah@biolojic.com